{"retracted":false,"update":{"timestamp":1477958400000,"doi":"10.1016/j.clinthera.2016.09.017","type":"err"},"doi":"10.1016/j.clinthera.2016.03.038","journal":"Clinical Therapeutics","publisher":"Elsevier BV","title":"Corrigendum to “Initial Experience With Tofacitinib in Clinical Practice: Treatment Patterns and Costs of Tofacitinib Administered as Monotherapy or in Combination With Conventional Synthetic DMARDs in 2 US Health Care Claims Databases” Clin Ther 38 (2016) 1451-63"}
